CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis

Abstract Circular RNAs (circRNAs) play essential roles in tumorigenesis and tumor progression. CircRNA GFRA1 (circGFRA1) was dysregulated in many cancer samples and acted as an independent marker for prediction of survivals in various cancer patients. However, the functions and molecular mechanisms...

Full description

Bibliographic Details
Main Authors: Shuai Lv, Yingxia Li, Hanbing Ning, Meihui Zhang, Qiaoyu Jia, Xijuan Wang
Format: Article
Language:English
Published: Nature Portfolio 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-79321-y
_version_ 1818716218753810432
author Shuai Lv
Yingxia Li
Hanbing Ning
Meihui Zhang
Qiaoyu Jia
Xijuan Wang
author_facet Shuai Lv
Yingxia Li
Hanbing Ning
Meihui Zhang
Qiaoyu Jia
Xijuan Wang
author_sort Shuai Lv
collection DOAJ
description Abstract Circular RNAs (circRNAs) play essential roles in tumorigenesis and tumor progression. CircRNA GFRA1 (circGFRA1) was dysregulated in many cancer samples and acted as an independent marker for prediction of survivals in various cancer patients. However, the functions and molecular mechanisms of circGFRA1 in hepatocellular carcinoma (HCC) remain unclear. We collected 62 HCC tissues and normal adjacent tissues to evaluate the expression of circGFRA1 and the relationship between circGFRA1 expression and HCC patients’ survival. We carried out a list of characterization experiments to investigate the roles and underling mechanisms of circGFRA1 and miR-498 in HCC progressions. CircGFRA1 was greatly increased in HCC tissues and cells, and the over-expression of circGFRA1 was intimately related with the advanced clinical stage and poor survival of HCC patients. The expression of circGFRA1 was negatively correlated with the expression of miR-498, but a positive correlation was found between circGFRA1 and NAP1L3 expression in HCC tissues. Silencing circGFRA1 inhibited the growth and invasion of hepatocellular carcinoma. Moreover, miR-498 over-expression or NAP1L3 inhibition could abrogate the oncogene role of circGFRA1 in HCC in vivo. Our findings indicated that circGFRA1 contributed to HCC progression by modulating the miR-498/NAP1L3 axis in HCC.
first_indexed 2024-12-17T19:15:46Z
format Article
id doaj.art-a78df13550b34a77af16de39faa15a30
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-17T19:15:46Z
publishDate 2021-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-a78df13550b34a77af16de39faa15a302022-12-21T21:35:45ZengNature PortfolioScientific Reports2045-23222021-01-0111111010.1038/s41598-020-79321-yCircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axisShuai Lv0Yingxia Li1Hanbing Ning2Meihui Zhang3Qiaoyu Jia4Xijuan Wang5Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Pediatrics, Henan Provincial People’s Hospital; Zhengzhou University People’s Hospital; Henan University People’s HospitalDepartment of Gastroenterology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Pediatrics, Henan Provincial People’s Hospital; Zhengzhou University People’s Hospital; Henan University People’s HospitalAbstract Circular RNAs (circRNAs) play essential roles in tumorigenesis and tumor progression. CircRNA GFRA1 (circGFRA1) was dysregulated in many cancer samples and acted as an independent marker for prediction of survivals in various cancer patients. However, the functions and molecular mechanisms of circGFRA1 in hepatocellular carcinoma (HCC) remain unclear. We collected 62 HCC tissues and normal adjacent tissues to evaluate the expression of circGFRA1 and the relationship between circGFRA1 expression and HCC patients’ survival. We carried out a list of characterization experiments to investigate the roles and underling mechanisms of circGFRA1 and miR-498 in HCC progressions. CircGFRA1 was greatly increased in HCC tissues and cells, and the over-expression of circGFRA1 was intimately related with the advanced clinical stage and poor survival of HCC patients. The expression of circGFRA1 was negatively correlated with the expression of miR-498, but a positive correlation was found between circGFRA1 and NAP1L3 expression in HCC tissues. Silencing circGFRA1 inhibited the growth and invasion of hepatocellular carcinoma. Moreover, miR-498 over-expression or NAP1L3 inhibition could abrogate the oncogene role of circGFRA1 in HCC in vivo. Our findings indicated that circGFRA1 contributed to HCC progression by modulating the miR-498/NAP1L3 axis in HCC.https://doi.org/10.1038/s41598-020-79321-y
spellingShingle Shuai Lv
Yingxia Li
Hanbing Ning
Meihui Zhang
Qiaoyu Jia
Xijuan Wang
CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
Scientific Reports
title CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
title_full CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
title_fullStr CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
title_full_unstemmed CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
title_short CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
title_sort circrna gfra1 promotes hepatocellular carcinoma progression by modulating the mir 498 nap1l3 axis
url https://doi.org/10.1038/s41598-020-79321-y
work_keys_str_mv AT shuailv circrnagfra1promoteshepatocellularcarcinomaprogressionbymodulatingthemir498nap1l3axis
AT yingxiali circrnagfra1promoteshepatocellularcarcinomaprogressionbymodulatingthemir498nap1l3axis
AT hanbingning circrnagfra1promoteshepatocellularcarcinomaprogressionbymodulatingthemir498nap1l3axis
AT meihuizhang circrnagfra1promoteshepatocellularcarcinomaprogressionbymodulatingthemir498nap1l3axis
AT qiaoyujia circrnagfra1promoteshepatocellularcarcinomaprogressionbymodulatingthemir498nap1l3axis
AT xijuanwang circrnagfra1promoteshepatocellularcarcinomaprogressionbymodulatingthemir498nap1l3axis